← Back to Screener
P3 Health Partners Inc. Common Stock (PIII)
Price$11.58
Value ScoreA
Growth ScoreC
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)106.52%
Price vs S&P 500 (4W)226.40%
VGM Score69.85
Market Capitalization$83.90M
All Metrics
Book Value / Share (Quarterly)$13.60
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)11.61%
Cash Flow / Share (Quarterly)$-25.91
Price vs S&P 500 (YTD)223.65%
Gross Margin (TTM)-0.75%
Net Profit Margin (TTM)-8.57%
EPS (TTM)$-38.77
10-Day Avg Trading Volume0.21M
EPS Excl Extra (TTM)$-38.77
Revenue Growth (5Y)24.62%
EPS (Annual)$-45.26
ROI (Annual)-58.87%
Gross Margin (Annual)-4.12%
Net Profit Margin (5Y Avg)-14.81%
Cash / Share (Quarterly)$7.74
Revenue Growth QoQ (YoY)3.53%
ROA (Last FY)-22.53%
Revenue Growth TTM (YoY)-0.87%
EBITD / Share (TTM)$-30.67
ROE (5Y Avg)-1098.22%
Operating Margin (TTM)-15.21%
Cash Flow / Share (Annual)$-27.77
P/B Ratio1.89x
P/B Ratio (Quarterly)1.02x
Net Income / Employee (Annual)$-462,300
EV / Revenue (TTM)0.25x
Net Interest Coverage (TTM)-4.83x
ROA (TTM)-18.39%
EPS Incl Extra (Annual)$-45.26
Current Ratio (Annual)0.24x
Quick Ratio (Quarterly)0.30x
3-Month Avg Trading Volume0.94M
52-Week Price Return78.15%
Revenue / Employee (TTM)$4,600,800
Tangible BV / Share (Quarterly)$-4.38
P/S Ratio (Annual)0.06x
Asset Turnover (Annual)2.22x
52-Week High$16.89
Operating Margin (5Y Avg)-46.27%
EPS Excl Extra (Annual)$-45.26
26-Week Price Return114.44%
Quick Ratio (Annual)0.22x
13-Week Price Return392.77%
Total Debt / Equity (Annual)2.04x
Current Ratio (Quarterly)0.33x
Enterprise Value$370.24M
Revenue / Share Growth (5Y)107.26%
Asset Turnover (TTM)2.14x
Revenue / Employee (Annual)$4,559,600
Pretax Margin (Annual)-22.00%
Cash / Share (Annual)$7.61
3-Month Return Std Dev393.80%
Gross Margin (5Y Avg)-1.95%
Net Income / Employee (TTM)$-394,500
ROE (Last FY)-178.90%
Net Interest Coverage (Annual)-3.53x
EPS Basic Excl Extra (Annual)$-45.26
Receivables Turnover (TTM)11.58x
Total Debt / Equity (Quarterly)4.10x
EPS Incl Extra (TTM)$-38.77
Receivables Turnover (Annual)13.65x
ROI (TTM)-61.67%
P/S Ratio (TTM)0.06x
Pretax Margin (5Y Avg)-47.51%
Revenue / Share (Annual)$446.34
Tangible BV / Share (Annual)$-17.92
Price vs S&P 500 (52W)53.79%
Year-to-Date Return231.81%
5-Day Price Return-10.30%
EPS Normalized (Annual)$-45.26
ROA (5Y Avg)-16.80%
Net Profit Margin (Annual)-10.14%
Month-to-Date Return-4.93%
Cash Flow / Share (TTM)$-7.38
EBITD / Share (Annual)$-56.94
Operating Margin (Annual)-18.53%
LT Debt / Equity (Annual)1.18x
ROI (5Y Avg)-110.68%
LT Debt / Equity (Quarterly)2.29x
EPS Basic Excl Extra (TTM)$-38.77
P/B Ratio (Annual)1.06x
Pretax Margin (TTM)-19.42%
Book Value / Share (Annual)$23.31
Price vs S&P 500 (13W)384.51%
Beta1.68x
Revenue / Share (TTM)$174.91
ROE (TTM)-191.97%
52-Week Low$1.52
vGradeA
gGradeC
mGradeB
vgmGradeB
Show chart for
Earnings Surprise History
Q1 260.32est. -3.58
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00
Industry Peers — Health Services(21)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PIIIP3 Health Partners Inc. Common Stock | A | C | B | $11.58 |
| LFSTLifeStance Health Group, Inc. Common Stock | D | B | C | $7.41 |
| PRVAPrivia Health Group, Inc. Common Stock | D | B | D | $21.63 |
| WGSGeneDx Holdings Corp. Class A Common Stock | F | B | D | $52.21 |
| PNTGThe Pennant Group, Inc. Common Stock | C | B | C | $31.71 |
| OMDAOmada Health, Inc. Common Stock | D | A | B | $17.93 |
| INNVInnovAge Holding Corp. Common Stock | D | C | C | $7.30 |
| USPHUS Physical Therapy Inc | C | C | D | $63.45 |
| TALKTalkspace, Inc. Common Stock | F | B | B | $5.22 |
| SRTAStrata Critical Medical, Inc. Class A Common Stock | C | A | B | $5.79 |
| ALPSALPS Group Inc Ordinary Share | — | — | F | $0.71 |
About
P3 Health Partners is a population health management company that coordinates care delivery across networks of community-based healthcare providers. The company aggregates existing healthcare resources to facilitate integrated, coordinated care aimed at improving patient outcomes and reducing costs. Its physician-led model aligns providers around shared quality and cost metrics.